Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A PROSPECTIVE MULTINATIONAL STUDY OF THE NATURAL HISTORY OF PARTICIPANTS WITH BAG3 MUTATION ASSOCIATED DILATED CARDIOMYOPATHY

NCT05981092 is registered in ClinicalTrials.gov with Alexion Pharmaceuticals, Inc. as lead sponsor.

NCT NCT05981092
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05981092 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A PROSPECTIVE MULTINATIONAL STUDY OF THE NATURAL HISTORY OF PARTICIPANTS WITH BAG3 MUTATION ASSOCIATED DILATED CARDIOMYOPATHY
Lead sponsor
Alexion Pharmaceuticals, Inc.
Phase
Observational
Overall status
Active, not recruiting
Start date
October 14, 2022
Completion date
August 12, 2027
Enrollment
35 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

bcl-2 anathogene-3 (bag3) dilated cardiomyopathy (dcm), cardiomyopathy, dilated